Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-16 Sale | 2026-03-18 4:07 pm | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $16.15 | $411,607 | 367,130 (Direct) | View |
| 2025-11-14 Sale | 2025-11-17 4:05 pm | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 11,367 | $14.33 | $162,937 | 16,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-31 Option Award | 2026-04-01 4:05 pm | N/A 2036-03-31 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,339 | $12.13 | 1,339 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-01 4:05 pm | N/A 2036-03-31 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 1,370 | $12.13 | 1,370 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:14 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:12 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:12 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 64,866 | $0 | 154,981 (Direct) | View |
| 2026-03-28 Tax Withholding | 2026-03-31 4:11 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 21,892 | $13.89 | 154,981 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 24,200 | $0 | 57,497 (Direct) | View |
| 2026-03-28 Tax Withholding | 2026-03-31 4:10 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 8,241 | $13.89 | 57,497 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:09 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,166 | $0 | 9,500 (Direct) | View |
| 2026-03-28 Exercise | 2026-03-31 4:09 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 3,166 | $0 | 6,333 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 19,500 | $12.65 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A 2034-07-15 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 25,492 | $0 | 367,130 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 4:07 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 5,992 | $8.04 | 367,130 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:24 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:23 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:23 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:22 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Boyd Taylor Chief Business Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:22 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-26 Option Award | 2026-03-02 4:20 pm | N/A 2036-02-26 | Avalo Therapeutics Inc. | AVTX | NEIL GARRY ARTHUR Chief Executive Officer | 286,000 | $0 | 286,000 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:05 pm | N/A 2035-12-31 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 848 | $14.74 | 848 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:05 pm | N/A 2035-12-31 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,043 | $14.74 | 1,043 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Doyle Mittie Chief Medical Officer | 1,013 | $4.1 | 3,622 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:18 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Riley Jennifer Chief Strategy Officer | 637 | $4.1 | 2,655 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:17 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | VARKI PAUL Chief Legal Officer | 1,016 | $4.1 | 3,634 (Direct) | View |
| 2025-12-10 Tax Withholding | 2025-12-12 4:17 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Sullivan Christopher Ryan Chief Financial Officer | 155 | $4.1 | 17,338 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-17 4:05 pm | N/A 2034-08-13 | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 8,200 | $0 | 16,400 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-17 4:05 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 8,200 | $9.88 | 16,400 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-06 4:28 pm | N/A 2035-10-01 | Avalo Therapeutics Inc. | AVTX | Boyd Taylor Chief Business Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 4:23 pm | N/A 2035-10-01 | Avalo Therapeutics Inc. | AVTX | Lind Kevin Robert Director | 40,200 | $0 | 40,200 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-02 4:11 pm | N/A 2035-09-30 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 1,572 | $0 | 1,572 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:44 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:39 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:35 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:30 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | KAPLAN GILLA Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:25 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | KANTOFF AARON Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:19 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Heffernan Michael Thomas Director | 29,500 | $0 | 29,500 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:13 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Almenoff June Sherie Director | 20,100 | $0 | 20,100 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 4:08 pm | N/A 2035-06-17 | Avalo Therapeutics Inc. | AVTX | Jain Rita Director | 40,200 | $0 | 40,200 (Direct) | View |
| 2025-03-28 Exercise | 2025-04-01 8:06 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Chan Mitchell Director | 3,167 | $0 | 9,500 (Direct) | View |
| 2025-03-28 Exercise | 2025-04-01 4:55 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Goldman Jonathan Director | 3,167 | $0 | 9,500 (Direct) | View |
| 2025-03-28 Exercise | 2025-04-01 4:44 pm | N/A N/A | Avalo Therapeutics Inc. | AVTX | Truex Samantha Director | 3,167 | $0 | 9,500 (Direct) | View |